1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Aspirin 1.2.3 Ibuprofen 1.2.4 Naproxen 1.2.5 Celecoxib 1.2.6 Others 1.3 Market by Application 1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Drug Store 1.3.3 Hospital Pharmacies 1.3.4 Online 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2016-2027) 2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions 2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2016-2021) 2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027) 2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic 2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends 2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers 2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges 2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue 3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2016-2021) 3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2016-2021) 3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue 3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio 3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020 3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served 3.6 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service 3.7 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type 4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2016-2021) 4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027) 5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application 5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2016-2021) 5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027) 6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type 6.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) 6.2.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) 6.2.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027) 6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application 6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) 6.3.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) 6.3.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027) 6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country 6.4.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) 6.4.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027) 7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type 7.2.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) 7.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) 7.2.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027) 7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application 7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) 7.3.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) 7.3.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027) 7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country 7.4.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) 7.4.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027) 8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type 8.2.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027) 8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application 8.3.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027) 8.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region 8.4.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027) 9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type 9.2.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) 9.2.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) 9.2.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027) 9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application 9.3.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) 9.3.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) 9.3.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027) 9.4 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country 9.4.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) 9.4.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027) 10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type 10.2.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027) 10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application 10.3.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027) 10.4 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country 10.4.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche (Genentech) 11.1.1 Roche (Genentech) Company Details 11.1.2 Roche (Genentech) Business Overview 11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.1.5 Roche (Genentech) Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview 11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.2.5 Amgen Recent Development 11.3 B-MS 11.3.1 B-MS Company Details 11.3.2 B-MS Business Overview 11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.3.5 B-MS Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.4.5 Merck Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.6.5 Novartis Recent Development 11.7 Eli Lilly and Company 11.7.1 Eli Lilly and Company Company Details 11.7.2 Eli Lilly and Company Business Overview 11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.7.5 Eli Lilly and Company Recent Development 11.8 Johnson & Johnson 11.8.1 Johnson & Johnson Company Details 11.8.2 Johnson & Johnson Business Overview 11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.8.5 Johnson & Johnson Recent Development 11.9 GSK 11.9.1 GSK Company Details 11.9.2 GSK Business Overview 11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.9.5 GSK Recent Development 11.10 Sanofi 11.10.1 Sanofi Company Details 11.10.2 Sanofi Business Overview 11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.10.5 Sanofi Recent Development 11.11 Boehringer Ingelheim 11.11.1 Boehringer Ingelheim Company Details 11.11.2 Boehringer Ingelheim Business Overview 11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.11.5 Boehringer Ingelheim Recent Development 11.12 Zhejiang Jiuzhou Pharmaceutical 11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details 11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview 11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) 11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Aspirin Table 3. Key Players of Ibuprofen Table 4. Key Players of Naproxen Table 5. Key Players of Celecoxib Table 6. Key Players of Others Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2016-2021) Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027) Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2016-2021) Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020) Table 20. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service Table 24. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million) Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021) Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2016-2021) Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million) Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million) Table 37. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million) Table 64. Roche (Genentech) Company Details Table 65. Roche (Genentech) Business Overview Table 66. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 67. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 68. Roche (Genentech) Recent Development Table 69. Amgen Company Details Table 70. Amgen Business Overview Table 71. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 72. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 73. Amgen Recent Development Table 74. B-MS Company Details Table 75. B-MS Business Overview Table 76. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 77. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 78. B-MS Recent Development Table 79. Merck Company Details Table 80. Merck Business Overview Table 81. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 82. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 83. Merck Recent Development Table 84. Pfizer Company Details Table 85. Pfizer Business Overview Table 86. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 87. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 88. Pfizer Recent Development Table 89. Novartis Company Details Table 90. Novartis Business Overview Table 91. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 92. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 93. Novartis Recent Development Table 94. Eli Lilly and Company Company Details Table 95. Eli Lilly and Company Business Overview Table 96. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 97. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 98. Eli Lilly and Company Recent Development Table 99. Johnson & Johnson Company Details Table 100. Johnson & Johnson Business Overview Table 101. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 102. Johnson & Johnson Recent Development Table 103. GSK Company Details Table 104. GSK Business Overview Table 105. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 106. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 107. GSK Recent Development Table 108. Sanofi Company Details Table 109. Sanofi Business Overview Table 110. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 111. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 112. Sanofi Recent Development Table 113. Boehringer Ingelheim Company Details Table 114. Boehringer Ingelheim Business Overview Table 115. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 116. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 117. Boehringer Ingelheim Recent Development Table 118. Zhejiang Jiuzhou Pharmaceutical Company Details Table 119. Zhejiang Jiuzhou Pharmaceutical Business Overview Table 120. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Table 121. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million) Table 122. Zhejiang Jiuzhou Pharmaceutical Recent Development Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2027 Figure 2. Aspirin Features Figure 3. Ibuprofen Features Figure 4. Naproxen Features Figure 5. Celecoxib Features Figure 6. Others Features Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2027 Figure 8. Drug Store Case Studies Figure 9. Hospital Pharmacies Case Studies Figure 10. Online Case Studies Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2027 Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027) Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2020 Figure 17. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020 Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021) Figure 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027) Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027) Figure 23. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027) Figure 24. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027) Figure 25. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027) Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027) Figure 30. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027) Figure 31. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027) Figure 39. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027) Figure 40. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2016-2027) Figure 41. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027) Figure 49. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027) Figure 50. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027) Figure 51. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027) Figure 55. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027) Figure 56. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027) Figure 57. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 61. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 62. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 63. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 66. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 67. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 68. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 69. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 70. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 71. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed